Donna Niedzwiecki
#157,482
Most Influential Person Now
Researcher
Donna Niedzwiecki's AcademicInfluence.com Rankings
Donna Niedzwieckiengineering Degrees
Engineering
#6635
World Rank
#7971
Historical Rank
Electrical Engineering
#2003
World Rank
#2106
Historical Rank
Donna Niedzwieckicomputer-science Degrees
Computer Science
#8756
World Rank
#9206
Historical Rank
Computational Linguistics
#2010
World Rank
#2032
Historical Rank
Machine Learning
#3672
World Rank
#3718
Historical Rank
Artificial Intelligence
#3982
World Rank
#4040
Historical Rank
Download Badge
Engineering Computer Science
Donna Niedzwiecki's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Donna Niedzwiecki Influential?
(Suggest an Edit or Addition)Donna Niedzwiecki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. (2008) (1229)
- Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). (2010) (790)
- Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. (2006) (698)
- Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison (2005) (652)
- Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. (2008) (648)
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial (2017) (580)
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer (2018) (557)
- Impact of number of nodes retrieved on outcome in patients with rectal cancer. (2001) (546)
- Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. (2002) (534)
- CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). (2014) (430)
- Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. (2007) (430)
- Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. (2007) (428)
- Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. (2003) (387)
- Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. (2009) (376)
- Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). (2006) (349)
- Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1 (2005) (340)
- Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). (2016) (311)
- Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. (2002) (306)
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. (2008) (301)
- The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. (2007) (295)
- Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. (2004) (292)
- FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. (1992) (287)
- Characterization of sporadic colon cancer by patterns of genomic instability. (2003) (284)
- Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors (1993) (266)
- Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. (2004) (262)
- Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. (2007) (250)
- A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB (2007) (249)
- Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. (2008) (247)
- Pain and depression in patients with newly diagnosed pancreas cancer. (1995) (223)
- Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. (1990) (221)
- A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer (1992) (221)
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 (2009) (194)
- Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. (2009) (189)
- Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. (2006) (184)
- Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. (2007) (182)
- Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. (2019) (182)
- Interferon-α with Zidovudine: Safety, Tolerance, and Clinical and Virologic Effects in Patients with Kaposi Sarcoma Associated with the Acquired Immunodeficiency Syndrome (AIDS) (1990) (178)
- Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. (2018) (178)
- Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. (2011) (167)
- Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. (2001) (156)
- Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. (2013) (155)
- Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. (2012) (149)
- Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. (2013) (143)
- Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. (1990) (141)
- Sentinel Node Staging of Resectable Colon Cancer: Results of a Multicenter Study (2004) (140)
- Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). (2019) (137)
- Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. (2004) (136)
- Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. (2005) (134)
- Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor. (1993) (132)
- Unrelated umbilical cord blood transplantation in adult patients. (2003) (132)
- Immune reconstitution after unrelated cord blood transplantation. (2007) (132)
- Long-term follow-up of Hodgkin's disease trial. (2002) (131)
- Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. (2006) (130)
- Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results. (2006) (130)
- Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory Molecules (2005) (129)
- Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. (2000) (126)
- Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. (2015) (125)
- Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. (2011) (116)
- Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial (2018) (114)
- 501OCALGB/SWOG 80405: PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN (FOLFIRI) OR OXALIPLATIN/5-FU/LEUCOVORIN (MFOLFOX6) WITH BEVACIZUMAB (BV) OR CETUXIMAB (CET) FOR PATIENTS (PTS) WITH EXPANDED RAS ANALYSES UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON OR RECTUM (MCRC) (2014) (114)
- Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement (1989) (113)
- Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers (2004) (112)
- A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer (2013) (112)
- Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. (1992) (111)
- CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. (2014) (107)
- An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. (2010) (102)
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. (1990) (101)
- Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. (2020) (101)
- Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. (2003) (99)
- Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). (2017) (97)
- Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma (2004) (92)
- APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q1 (2004) (92)
- Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). (2012) (91)
- Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. (2012) (90)
- Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease. (1993) (87)
- Prospective comparison of patient experience with colon imaging tests. (2006) (87)
- A phase III comparison trial of streptozotocin, mitomycin, and 5‐fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma (1991) (82)
- Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. (2009) (79)
- A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). (2010) (79)
- Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. (2011) (77)
- Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. (1992) (77)
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer (2019) (76)
- Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104) (2012) (76)
- Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803) (2004) (74)
- Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. (1993) (74)
- Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). (2017) (73)
- Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance). (2015) (73)
- Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. (2011) (72)
- Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration. (2017) (71)
- Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer. (1990) (71)
- Enumerating Antigen-Specific T-Cell Responses in Peripheral Blood: A Comparison of Peptide MHC Tetramer, ELISpot, and Intracellular Cytokine Analysis (2005) (71)
- Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206 (2007) (71)
- Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial (2019) (70)
- CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. (2016) (70)
- Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. (2006) (68)
- Association of family history with cancer recurrence and survival among patients with stage III colon cancer. (2008) (67)
- Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) (2014) (67)
- Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. (2019) (67)
- Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo. (1996) (65)
- Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump (1992) (63)
- Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer. (2017) (62)
- Impact of smoking on patients with stage III colon cancer (2010) (61)
- Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance) (2014) (61)
- Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. (1993) (59)
- CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer. (2010) (59)
- Flow cytometry as a predictive indicator in patients with operable gastric cancer. (1989) (58)
- Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia. (1991) (58)
- A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases (1993) (57)
- How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? (2004) (55)
- Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803 (2005) (54)
- Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803). (2004) (54)
- Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance). (2017) (54)
- Metastatic Adenocarcinomas of Unknown Primary Site: Prognostic Variables and Treatment Results (1990) (54)
- Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). (2015) (54)
- Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. (1991) (53)
- Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19 (2021) (52)
- A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. (2014) (52)
- Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin. (1991) (50)
- Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781. (2006) (50)
- Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity (2009) (49)
- Evaluation of Microsatellite Instability, hMLH1 Expression and hMLH1 Promoter Hypermethylation in Defining the MSI Phenotype of Colorectal Cancer (2004) (49)
- Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain (2006) (48)
- Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. (2013) (48)
- Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281). (2008) (46)
- BACCI: A phase II randomized, double-blind, multicenter, placebo-controlled study of capecitabine (C) bevacizumab (B) plus atezolizumab (A) or placebo (P) in refractory metastatic colorectal cancer (mCRC): An ACCRU network study (2019) (45)
- Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (45)
- Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance) (2018) (44)
- Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2 (2007) (44)
- Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks. (1987) (44)
- In vitro neurogenesis by neuronal precursor cells derived from the adult songbird brain (1992) (44)
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. (2019) (44)
- Heterogeneity of Tardive Dyskinesia (1988) (44)
- A Phase II Trial of Streptozotocin and Adriamycin in Advanced APUD Tumors (1988) (43)
- Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance). (2016) (43)
- Insulin-Like Growth Factor-1 Is a Radial Cell-Associated Neurotrophin that Promotes Neuronal Recruitment from the Adult Songbird Ependyma/Subependyma (1998) (43)
- Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline. (1986) (42)
- Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. (2019) (41)
- Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. (1987) (41)
- Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance) (2017) (41)
- Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901 (2007) (40)
- Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803 (2013) (40)
- Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines. (1992) (37)
- Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. (2013) (36)
- Thymic epithelial defects and predisposition to autoimmune disease in BB rats. (1994) (36)
- Long-term follow-up of survival in Hodgkin's lymphoma. (2009) (34)
- Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. (2010) (34)
- Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) (1990) (34)
- System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation. (2020) (33)
- Safety of nifedipine in angina pectoris: a meta-analysis. (1999) (33)
- The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies. (1987) (32)
- Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. (2010) (32)
- Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance) (2019) (31)
- A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction che (2006) (31)
- Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. (2021) (31)
- Immune reconstitution in children after unrelated cord blood transplantation. (2008) (31)
- p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803 (2009) (30)
- 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). (2014) (30)
- Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma. (2005) (30)
- Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B (2008) (29)
- AIDS-associated Kaposi's sarcoma: variables associated with survival. (1988) (28)
- Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202). (2019) (28)
- Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine. (1989) (28)
- A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma (2011) (27)
- Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer. (1992) (26)
- Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. (2018) (26)
- O-0019CALGB/SWOG 80405: PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN (FOLFIRI) OR OXALIPLATIN/5-FU/LEUCOVORIN (MFOLFOX6) WITH BEVACIZUMAB (BV) OR CETUXIMAB (CET) FOR PATIENTS (PTS) WITH KRAS WILD-TYPE (WT) UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON (2014) (25)
- A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603 (2008) (25)
- The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803 (2005) (24)
- Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency (2004) (24)
- Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405. (2015) (24)
- High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses. (1987) (24)
- Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance). (2017) (23)
- Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site. (1995) (23)
- Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581. (2011) (23)
- A Phase II Prospective Multi-Institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903 (2009) (23)
- LBA10CALGB/SWOG 80405: ANALYSIS OF PATIENTS UNDERGOING SURGERY AS PART OF TREATMENT STRATEGY (2014) (22)
- Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients. (2017) (22)
- Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). (2015) (22)
- Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104) (2006) (22)
- Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial (2021) (22)
- Safety of nifedipine in patients with hypertension: a meta-analysis. (1997) (21)
- Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer (2022) (21)
- Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance) (2019) (20)
- Phase 2 Study of the g209-2M Melanoma Peptide Vaccine and Low-Dose Interleukin-2 in Advanced Melanoma: Cancer and Leukemia Group B 509901 (2006) (20)
- Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) (2018) (20)
- Histology of early lesions of AIDS-associated Kaposi's sarcoma. (1990) (19)
- Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indications. (2010) (19)
- Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer. (2020) (19)
- A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA) (1991) (19)
- MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial (2014) (18)
- Cisplatin and 5‐fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates (1989) (18)
- Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing. (1992) (18)
- Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio (2020) (18)
- Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) (2016) (18)
- Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer. (2006) (18)
- Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. (2013) (17)
- A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904). (2004) (17)
- Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255 (2000) (17)
- Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. (2019) (17)
- Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance) (2018) (17)
- A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803 (2016) (17)
- A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection (2019) (17)
- Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects (2012) (17)
- Low‐dose weekly paclitaxel for recurrent or refractory aggressive non‐Hodgkin lymphoma (2004) (16)
- Insulin-like growth factor-1 is a radial cell-associated neurotrophin that promotes neuronal recruitment from the adult songbird edpendyma/subependyma. (1998) (16)
- Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine (2009) (16)
- Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. (2007) (16)
- Phase II study of oral eniluracil, 5‐fluorouracil, and leucovorin in patients with advanced colorectal carcinoma (2001) (15)
- Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study (2015) (15)
- A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER). (2017) (15)
- Treatment Outcomes in Anaplastic Thyroid Cancer (2019) (14)
- Prolonged follow‐up after initial therapy with 2‐chlorodeoxyadenosine in patients with indolent non‐Hodgkin lymphoma (2006) (14)
- Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. (2019) (14)
- Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581). (2004) (14)
- Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance). (2016) (13)
- Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). (2017) (13)
- Evaluation of New Anticancer Agents Against Human Pancreatic Carcinomas in Nude Mice (1987) (13)
- Early 18F-FDG-PET Response During Radiotherapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence. (2020) (13)
- Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance) (2018) (13)
- Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients (2015) (12)
- Probiotics in Inflammatory Bowel Disease: Yet Another Mechanism of Action? (2009) (12)
- Use of Skeletal Muscle Index as a Predictor of Wait‐List Mortality in Patients With End‐Stage Liver Disease (2020) (12)
- Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls. (2011) (12)
- Phase III trial of adjuvant immunotherapy with MOAb 17–1A following resection for stage II adenocarcinoma of the colon (CALGB 9581) (2004) (12)
- Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs. (1987) (11)
- A Phase II Prospective Multi-institutional Trial of Adjuvant Active Specific Immunotherapy Following Curative Resection of Colorectal Cancer Hepatic Metastases: Cancer and Leukemia Group B Study 89903 (2007) (11)
- Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma (1989) (11)
- A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial) (2019) (11)
- Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581. (2009) (11)
- The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation (2018) (11)
- A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206. (2006) (11)
- CALGB 59901: Results of a Phase II Study of 506U78 in CTCL and PTCL. (2004) (10)
- A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC 1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer (2013) (10)
- Genetic variation determines VEGF-A plasma levels in cancer patients (2018) (10)
- Quality of life (QOL) and toxicity among patients in CALGB 80405. (2013) (10)
- Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers. (2021) (10)
- Metastatic Prostate Cancer T Cell Responses in Patients with + CD4 and + Cells Stimulate Antigen-Specific CD8 Telomerase mRNA-Transfected Dendritic (2005) (9)
- Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance) (2018) (9)
- Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma. (1992) (9)
- A phase I/II study of preoperative oxaliplatin (O), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901. (2004) (9)
- Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (9)
- Phase I study of pazopanib plus TH-302 in advanced solid tumors (2017) (9)
- A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study. (2011) (8)
- Diet- and Lifestyle‐Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance) (2022) (8)
- Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity (2005) (8)
- Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. (2019) (8)
- A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer (2019) (8)
- Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. (2021) (8)
- Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405. (2021) (8)
- Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance). (2017) (7)
- Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria. (2019) (7)
- Phase Ib/II study of pembrolizumab with lanreotide depot for advanced, progressive gastroenteropancreatic neuroendocrine tumors (PLANET). (2021) (7)
- Impact of age and comorbidities on treatment effect, tolerance, and toxicity in metastatic colorectal cancer (mCRC) patients treated on CALGB 80203. (2009) (7)
- KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803. (2016) (7)
- Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103 (2005) (7)
- Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581. (2014) (7)
- The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis of host, graft, and day +50 immune profile (2004) (7)
- Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405 (2020) (7)
- Oncology clinical trials (2013) (7)
- Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease. (2008) (7)
- The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. (2018) (6)
- An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance) (2019) (6)
- Relationship and Prognostic Value of Endogenous Interferon-α, β2-Microglobulin, and Neopterin Serum Levels in Patients with Kaposi Sarcoma and AIDS (1991) (6)
- Causes of errors in polyp detection at air-contrast barium enema examination. (2006) (6)
- Estimation and inference in pharmacokinetic models: The effectiveness of model reformulation and resampling methods for functions of parameters (1990) (6)
- LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402 (2008) (6)
- Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C (2020) (6)
- The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803 (2008) (6)
- American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance). (2017) (6)
- Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance). (2017) (6)
- BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer. (2018) (6)
- Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) (2022) (5)
- Fibrin glue as an adjuvant dural sealant reduces the rate of perioperative complications in posterior fossa decompression with duraplasty: A single center experience in 165 adult Chiari I patients (2019) (5)
- Multivariate Analysis of Patient and Graft Specific Factors among 330 Recipients of Unrelated Cord Blood Transplant (UCBT) To Predict Risk of Death from Opportunistic Infections in the First 6 Months after UCBT. (2006) (5)
- Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. (2006) (5)
- Big Data, Small Effects. (2016) (5)
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria. (2020) (5)
- Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906 (2006) (5)
- Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease (2004) (4)
- Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP) (2021) (4)
- Associations of physical activity with survival and progression in metastatic colorectal cancer: Results from CALGB 80405 (Alliance). (2017) (4)
- A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors (2019) (4)
- Variability in endoscopic assessment of Nissen fundoplication wrap integrity and hiatus herniation. (2021) (4)
- The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance) (2020) (4)
- LBA21_PRProspective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy) (2017) (4)
- Sentinel node staging of resectable colon cancer: Results of CALGB 80001. (2004) (4)
- Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B. (2000) (4)
- Evaluating for disparities in place of death for head and neck cancer patients in the United States utilizing the CDC WONDER database. (2020) (4)
- Esophageal Function Tests are Not Associated with Barium Swallow Findings in Advanced Lung Disease (2020) (4)
- Predictors of Abnormal Functional Luminal Impedance Planimetry Findings in Non-mechanical Esophagogastric Junction Outflow Obstruction (2020) (4)
- Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial (2020) (4)
- Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents. (2020) (3)
- Predictors of Clinical Outcome after Treatment of Intracranial Aneurysms with the Pipeline Embolization Device (PED). (2019) (3)
- Comparison of survival of stage I–III colon cancer by travel distance and hospital volume (2020) (3)
- Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC). (2016) (3)
- Use, Yield, and Risk of Device-assisted Enteroscopy in the United States (2020) (3)
- A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity. (2018) (3)
- Multiagent Chemotherapy for Isolated Colorectal Liver Metastases: A Single-centered Retrospective Study (2008) (3)
- p 27 Kip 1 in Stage IIIColon Cancer : Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group BProtocol 89803 (2009) (3)
- Accuracy of a Natural Language Processing Pipeline to Identify Patient Symptoms during Radiation Therapy (2019) (3)
- Advancing Precision Oncology Through Biomarker-Driven Trials: Theory vs. Practice (2019) (3)
- Association of RAS mutations with race in metastatic colorectal cancer: CALGB/SWOG 80405 (ALLIANCE). (2018) (3)
- A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood. (2018) (3)
- IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405 (2020) (3)
- Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer (2021) (3)
- Congenital human cytomegalovirus infection is associated with decreased transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia. (2021) (3)
- High Dose Cyclophosphamide Plus Recombinant Human Granulocyte-colony Stimulating Factor (rhG-CSF) in the Treatment of Follicular, Low Grade Non-Hodgkin's Lymphoma: CALGB 9150 (2001) (2)
- Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors. (2005) (2)
- Image quality and Dose Comparison of Three Mobile Intraoperative 3D imaging Systems in Spine Surgery. (2021) (2)
- High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150. (2001) (2)
- Title Identification of a Genomic Region between SLC 29 A 1 and HSP 90 AB 1 Associated with Risk of Bevacizumab-Induced Hypertension : CALGB 80405 ( Alliance ) (2018) (2)
- Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions (2021) (2)
- Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL). (2016) (2)
- Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405. (2015) (2)
- Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance) (2021) (2)
- Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma (2005) (2)
- Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702. (2020) (2)
- Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells. (2010) (2)
- Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion (2020) (2)
- Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance) (2021) (2)
- Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases (1993) (2)
- Recumbent Total Skin Electron Beam Therapy (2021) (2)
- Topical sildenafil in the treatment of hand-foot syndrome and hand-foot skin reaction: A retrospective study. (2018) (1)
- A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. (2015) (1)
- Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the phenotype of colorectal cancer: a study from CALGB 9865 (2003) (1)
- Gastric Emptying Is Not Associated With Esophageal Motility Pattern or Patient Outcomes After Lung Transplantation (2018) (1)
- KEYlargo: A phase II study of first-line pembrolizumab (P), capecitabine (C), and oxaliplatin (O) in HER2-negative gastroesophageal (GE) adenocarcinoma. (2021) (1)
- Correction to: Esophageal Function Tests are Not Associated with Barium Swallow Findings in Advanced Lung Disease (2020) (1)
- Need for Pretransplant Midodrine Does Not Negatively Impact Simultaneous Liver-kidney Transplant Outcomes (2020) (1)
- Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment (2020) (1)
- Early Imaging Characteristics Associated with Development of Future Brain Metastases in Patients Undergoing Stereotactic Radiosurgery (2022) (1)
- Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment (2019) (1)
- Cancer patient satisfaction with telehealth: Survey results from a large NCI-designated cancer institute. (2021) (1)
- Does Efficacy and Toxicity Differ According to Prostate Volume in Men Treated with Moderately Hypofractionated Radiation Therapy? (2020) (1)
- Analysis of Cellular Immune Responses in Cancer Vaccine Trials (2004) (1)
- The impact of dietary patterns on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803 (2007) (1)
- Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer (2022) (1)
- Effect of the vaccine Ad5 [E1-, E2b-]-CEA(6D) on CEA-directed CMI responses in patients with advanced CEA-expressing malignancies in a phase I/II clinical trial. (2012) (1)
- Cancer and Leukemia Group B Gastrointestinal Cancer Committee (2006) (1)
- A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients. (2011) (1)
- Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C (2020) (1)
- Phase I Study of Immunizationwith Dendritic Cells Modifiedwith Fowlpox Encoding Carcinoembryonic Antigen and CostimulatoryMolecules (2005) (1)
- Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report. (2004) (1)
- Long-Term Experience in an Equal Access Health Care System Using Moderately Hypofractionated Radiotherapy for High Risk Prostate Cancer in a Predominately African American Population With Unfavorable Disease (2020) (1)
- A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation (2010) (1)
- Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance) (2013) (1)
- Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy (2010) (1)
- Abstract 3285: Body mass index, weight loss, and progression and mortality in metastatic colorectal cancer: Results from CALGB/SWOG 80405 (Alliance) (2019) (1)
- Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary (1o) tumor side. (2017) (1)
- A phase II study of savolitinib (volitinib, AZD6094, HMPL-504) in subjects with MET amplified metastatic colorectal cancer (mCRC) detected by cell-free (cf)DNA. (2020) (1)
- Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives (2021) (1)
- Adaptive PET Radiation Therapy in Patients with Locally Advanced Vulvar Cancer: A Prospective Study (2022) (1)
- Effective pain control with very low dose palliative radiotherapy for multiple myeloma patients with painful osseous lesions (2020) (1)
- X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC). (2016) (1)
- 409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO) (2020) (1)
- Quality in Cancer Care: An Assessment of the American College of Surgeons Commission on Cancer Quality Measures (2017) (1)
- RADI-09. Clinical factors associated with death after radiotherapy for brain metastases (2021) (1)
- Impact of machine learning-directed on-treatment evaluations on cost of acute care visits: Economic analysis of SHIELD-RT. (2021) (1)
- Classification of older adults who underwent lumbar-related surgery using pre-operative biopsychosocial predictors and relationships with surgical recovery: An observational study conducted in the United States. (2021) (1)
- Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC). (2018) (1)
- Orthotopic Transplantation of the Full-length Porcine Intestine After Normothermic Machine Perfusion (2022) (1)
- Plasma protein markers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: Results from CALGB 80405 (Alliance). (2021) (1)
- Reply to L. Fornaro et al. (2018) (1)
- A novel interaction of genotype, gender, and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803. (2012) (1)
- Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children (2022) (1)
- Predictive and prognostic value of HER2 gene expression and HER2 amplification in patients with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance). (2020) (1)
- Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes (2022) (1)
- MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY (2022) (1)
- Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration (2014) (1)
- Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC). (2018) (0)
- Microsatellite-high (MSI-H) tumors are not associated with LOH at the APC locus compared to microsatellite-low/stable (MSI-L/MSS) tumors (2001) (0)
- Ipsilateral versus Bilateral Neck Radiation Therapy for Tonsillar Squamous Cell Carcinoma (2020) (0)
- Relative variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. (2019) (0)
- A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients. (2018) (0)
- 154 Is Statin Use at Time of Prostate Cancer Radiation Associated with Protection of Patient-reported Erectile Function? (2019) (0)
- Closed Incision Negative Pressure Therapy to Reduce Surgical Site Infection in High-Risk Gastrointestinal Surgery: A Randomized Controlled Trial. (2023) (0)
- nrelated Umbilical Cord Blood Transplantation in dult Patients (2003) (0)
- Clinical Utility of Near-infrared Device in Detecting Traumatic Intracranial Hemorrhage: A Pilot Study Toward Application as an Emergent Diagnostic Modality in a Low Resource Setting. (2022) (0)
- Oligometastases Treated With an Elective Simultaneous Integrated Boost Have Reduced Marginal Recurrence Rates. (2021) (0)
- Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL). (2004) (0)
- S1399 Impact of Time and Location of Diagnostic Paracentesis on Outcomes of Spontaneous Bacterial Peritonitis (2022) (0)
- Could Gene Assay Help Guide Stage II Colon Cancer Treatment (2016) (0)
- Hospital‐level compliance with the commission on cancer’s quality of care measures and the association with patient survival (2021) (0)
- Genetic variation determines VEGF-A plasma levels in cancer patients (2018) (0)
- Association between physical activity and the time course of cancer recurrence in stage III colon cancer (2023) (0)
- Mo1486 NAFLD WITH FIBROSIS IS ASSOCIATED WITH AN INCREASED RISK OF NON-HCC CANCER BURDEN: AN ANALYSIS OF PCORNET DATA (2020) (0)
- Primary Mediastinal (Thymic) Large B-cell Lymphoma: The Working Diagnosis vs WHO Classification Criteria (2020) (0)
- Reply to L. Casadaban et al. (2017) (0)
- Quality of Life Associated with Open vs Minimally Invasive Pancreaticoduodenectomy: A Prospective Pilot Study. (2022) (0)
- Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405. (2021) (0)
- Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers (2022) (0)
- 1411 POSTER Endpoints for Validation of Tumour Markers for Recurrence Risk -Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581 (2011) (0)
- Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance). (2021) (0)
- Toxicity and Early Clinical Outcomes for Sequential and Simultaneous Integrated Nodal Boost in Patients with Locally Advanced Cervical Cancer (2019) (0)
- Divergent Interpretations of Imaging after Stereotactic Body Radiation Therapy for Lung Cancer. (2022) (0)
- Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. (2022) (0)
- Dendritic cell and T-cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation in children: A multivariate analysis (2005) (0)
- Natural language processing to identify patient symptoms during and prior to cancer therapy (2018) (0)
- Chromosomal vs microsatellite instability in colorectal cancers: Evidence for previously unrecognized pathways (2001) (0)
- S1161 Financial Toxicity and Its Prevalence in Cirrhosis (2021) (0)
- Clinical Factors Associated With 30-Day Mortality Among Patients Undergoing Radiation Therapy for Brain Metastases (2023) (0)
- Impact of Target Volume and Image Guidance on Post-Prostatectomy Patients Treated With Intensity Modulated Radiation Therapy. (2021) (0)
- Surgical and Pathologic Outcomes in Patients on a Phase II Trial of Neoadjuvant Chemotherapy and Hypofractionated Image-Guided Intensity Modulated Radiation Therapy (HIGRT) in Resectable and Borderline Resectable Pancreatic Cancer (2018) (0)
- In reply [2] (2006) (0)
- Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin. (2022) (0)
- Establishing ADC-Based Histogram and Texture Features for Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma (2021) (0)
- Uncertainties in the dosimetric heterogeneity correction and its potential effect on local control in lung SBRT (2023) (0)
- ID: 3524478 THE UTILITY OF FAMILY HISTORY AS A RISK FACTOR IN IDENTIFYING PATIENTS WHO WOULD BENEFIT FROM SCREENING FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA (2021) (0)
- Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). (2014) (0)
- ID: 3524447 VARIABILITY IN ENDOSCOPIC ASSESSMENT OF NISSEN FUNDOPLICATION WRAP INTEGRITY AND HIATUS HERNIATION: A MULTI-CENTER STUDY (2021) (0)
- S1315 African American Race and Lack of Prior Cholecystectomy Are Associated With Positive Lactulose Hydrogen Breath Testing (2020) (0)
- Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer (2019) (0)
- S396 Higher Rates of Dysphagia Incidence Among Patients With Malignant Primary Brain Tumors Compared to Brain Metastases: A National Study of Medicare Beneficiaries (2022) (0)
- Sa1181 – Identifying Gastroesophageal Reflux Disease Post-Lung Transplant is Not Improved with Intraluminal Impedance Versus Ph-Metry (2019) (0)
- Reply to S. Sorscher. (2019) (0)
- Adaptive IMRT Planning Improves Pharyngeal Sparing for Oropharyngeal Cancer (2018) (0)
- Su1646 VALIDATION OF MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY RISK PREDICTION SCORES TO PREDICT CLINICAL EVENTS IN PRIMARY SCLEROSING CHOLANGITIS (2020) (0)
- Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis (2022) (0)
- Image quality of EOS low-dose radiography in comparison with conventional radiography for assessment of ventriculoperitoneal shunt integrity. (2021) (0)
- Dietary fat in relation to all‐cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405 (2022) (0)
- S668 Clinical Predictors of a Positive CT Angiogram Study Used for the Evaluation of Acute Gastrointestinal Hemorrhage (2021) (0)
- S1331 Antibiotic Resistance Rates in Helicobacter pylori Infection Derived from Retrospective Cure Rates (2020) (0)
- S1332 Variations and Racial Disparities in Helicobacter pylori Guideline Adherence for Eradication Testing (2020) (0)
- Acid exposure time is sensitive for detecting gastroesophageal reflux disease and is associated with long-term survival after lung transplant. (2022) (0)
- Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials. (2020) (0)
- Machine Learning Implementation Results in Reduced Variable Cost of Acute Care Visits During Radiotherapy: SHIELD-RT Cost Analysis (2021) (0)
- S270 Family History Screening Tool Reveals Gaps in Colorectal Cancer Screening and Surveillance (2021) (0)
- Su1002 CHOLECYSTECTOMY FOLLOWING CHOLEDOCHOLITHIASIS: THE EFFECT OF RACE AND ETHNICITY ON THE TIMELINESS OF SURGERY (2020) (0)
- Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer (PaRTNer): Longitudinal Assessment of Financial Toxicity and an Educational Intervention from a Pilot Study (2022) (0)
- Machine Learning Algorithm Prospectively Predicts Survival for High-Risk Patients Undergoing Radiotherapy: A Survival Analysis of SHIELD-RT. (2021) (0)
- Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting. (2022) (0)
- Clinical Features and Management of Small Bowel Masses Detected During Device-Assisted Enteroscopy: A Multi-Center Experience (2022) (0)
- 208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT) (2008) (0)
- Clinical Predictors of a Positive Ct Angiogram Study Used for the Evaluation of Acute Gastrointestinal Hemorrhage (2022) (0)
- Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation. (2005) (0)
- Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803 (2012) (0)
- Tumor markers of efficacy and resistance to cetuximab (C) treatment in metastatic colorectal cancer (mCRC): Results from CALGB 80203 (Alliance). (2013) (0)
- Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma. (2023) (0)
- Runx3: A novel tumor suppressor gene frequently inactivated by promoter hypermethylation in colon cancers-results from CALGB 9865 study (2003) (0)
- Interpreting Post-SBRT Lung Imaging: A Comparison of Radiology and Radiation Oncology Impressions. (2021) (0)
- Identification of an optimal circulating tumor DNA (ctDNA) shedding threshold to detect actionable driver mutations in colorectal and pancreatic adenocarcinoma. (2022) (0)
- Fluoropyrimidines by Leucovorin Role of Folylpolyglutamates in Biochemical Modulation of Updated (2006) (0)
- Sa1185 – Barium Swallow Findings Do Not Correlate with Esophageal Function Testing in Lung Transplant Candidates (2019) (0)
- Predicting Emergency Visits and Hospital Admissions in Radiation and Chemoradiation: Performance of a Pre-Treatment Machine Learning Algorithm on Different Disease Sites in an Internal Validation Cohort (2018) (0)
- 1089 Hypophosphatemia in Patients With Alcoholic Hepatitis (2019) (0)
- 25-hydroxyvitamin D levels and survival in patients with advanced pancreatic cancer (APC): Findings from CALGB 80303. (2013) (0)
- EP02.02-006 Differing Doses: The Effects of Radiation Dose Calculation Algorithms on Local Control in Early-Stage Lung Cancer (2022) (0)
- Surgical resection is associated with improved long-term survival of patients with resectable pancreatic head cancer compared to multiagent chemotherapy. (2021) (0)
- Reporting of Results: Data Analysis and Interpretation (2018) (0)
- S1081 Evaluation of Abbreviated HLD Protocols for Duodenoscopes With Disposable Tips (2022) (0)
- The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation, (2011) (0)
- Somatic frameshift mutations in MBD4 (MED1) are not exclusively associated with microsatellite high (MSI-H) colorectal tumors (2001) (0)
- S19 Patient Factors Associated With Oral Feeding Within 1 Day of Admission for Acute Pancreatitis in a Large Multihospital Health System (2021) (0)
- Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance) (2022) (0)
- Deletions in HSP110 T17 and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147. (2016) (0)
- Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines (2008) (0)
- Dendritic and T Cell Subsets Correlate with the Development and Site of Acute GVHD Following Unrelated Cord Blood Transplantation. A Multivariate Analysis of Host, Graft, and Day+50 Immune Profile. (2004) (0)
- Associations of insulin-like growth factor binding proteins and adiponectin with disease progression and mortality in metastatic colorectal cancer: Results from CALGB/SWOG 80405 (Alliance). (2019) (0)
- Current approach to health care transition and integration into adult care for pediatric liver transplant recipients: A call for partnership. (2023) (0)
- Lung Transplantation Alters Esophageal Motility and is Associated with Abnormal pH Testing: 35 (2010) (0)
- Tox ¡ city , Elimination , and Metabolism of 10-Ethyl-lO-deazaaminopterin in Rats and Dogs 1 (2006) (0)
- The Role of Hypofractionated Radiation Therapy in the Management of Unresectable Hepatocellular Carcinoma (HCC). (2021) (0)
- Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors (2006) (0)
- THE USE OF DEVICE-ASSISTED ENTEROSCOPY IN THE DIAGNOSIS AND MANAGEMENT OF SMALL BOWEL MASSES: A MULTI-CENTER EXPERIENCE (2022) (0)
- RADT-02. IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AND LOCAL CONTROL AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY (2022) (0)
- Toxicity and Dosimetric Parameters of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC). (2021) (0)
- Treatment of Mycosis Fungoides using a Recumbent Total Skin Electron Beam Technique: A Comparison of Dosimetric and Clinical Outcomes. (2020) (0)
- 2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405 (2015) (0)
- Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan. (2004) (0)
- Optimizing Management of the Central Nervous System in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplantation (2022) (0)
- A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer (2019) (0)
- Comparison of radiologists and technologists in the performance of air-contrast barium enemas. (2006) (0)
- Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery (2022) (0)
- S1071 Assessment of Pathogenic Enteric Flora Contaminating Novel Duodenoscopes With Disposable Tips (2022) (0)
- [Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis]. (1990) (0)
- Tu1049: IMPACT OF GI/HEPATOLOGY CONSULTATION ON OUTCOMES FOR SPONTANEOUS BACTERIAL PERITONITIS (2022) (0)
- p27 Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803 (2011) (0)
- Tu1534 THE USE OF DEVICE-ASSISTED ENTEROSCOPY IN DIAGNOSING AND TREATING SMALL BOWEL DISORDERS, RESULTS FROM A LARGE RETROSPECTIVE MUTLI-CENTER US STUDY (2020) (0)
- TIPS Outcomes According to Race and Ethnicity (2018) (0)
- Prospective Evaluation of Interim FDG-PET Imaging during Chemoradiation for Anal SCC (2022) (0)
- A panel of mono- and dinucleotide microsatellite markers is required for reliable determination of the MSI status in colorectal cancer (2001) (0)
- is merely a description of a new technology, more context would have helped me understand why this is anything other than a cool new gadget looking for investors. (2006) (0)
- Comparison of Deformable Pre-Brachytherapy MRI, CT, and Every Fraction MRI-Based Brachytherapy Treatment Planning for Locally Advanced Cervical Cancer (2019) (0)
- Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405. (2022) (0)
- Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identify a heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC). (2019) (0)
- DIGITAL HEALTH INTERVENTION DECREASES NO-SHOWS FOR ENDOSCOPIC PROCEDURES (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Donna Niedzwiecki?
Donna Niedzwiecki is affiliated with the following schools:
